| 000 | 01054 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518093313.0 | ||
| 264 | 0 | _c20201019 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1471-0528 | ||
| 024 | 7 |
_a10.1111/1471-0528.16229 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTai, Y-J | |
| 245 | 0 | 0 |
_aA switch to dactinomycin: what is the cutoff value for hCG? _h[electronic resource] |
| 260 |
_bBJOG : an international journal of obstetrics and gynaecology _c08 2020 |
||
| 300 |
_a1146 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aChorionic Gonadotropin |
| 650 | 0 | 4 | _aDactinomycin |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGestational Trophoblastic Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMethotrexate |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tBJOG : an international journal of obstetrics and gynaecology _gvol. 127 _gno. 9 _gp. 1146 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/1471-0528.16229 _zAvailable from publisher's website |
| 999 |
_c30790907 _d30790907 |
||